June 18, 2024Open Access

Figure 13 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity

Key points are not available for this paper at this time.

Fig. S13. MS workflow used to identify MHC class I peptides increased by treatment with HDAC6 inhibitors or bortezomib.

KI fragen

Bookmark

View Full Paper

Cite This Study

Rana et al. (Tue,) studied this question.

KI fragen

Bookmark

View Full Paper